Overview
Peter Lamparello is a Hematologist Oncology specialist and a Hematologist in Albany, New York. Dr. Lamparello is highly rated in 48 conditions, according to our data. His top areas of expertise are Thrombocytopenia, Protein C Deficiency, Protein S Deficiency, and Hereditary Resistance to Anti-Vitamin K.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 Patroon Creek Blvd, Suite 1, Albany, NY 12206
New York Oncology Hematology PC
Joseph Dudek is a Hematologist Oncology specialist and a Hematologist in Albany, New York. Dr. Dudek is highly rated in 103 conditions, according to our data. His top areas of expertise are Pulmonary Embolism, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Saddle Pulmonary Embolism.
New York Oncology Hematology PC
Lawrence Garbo is a Hematologist Oncology specialist and a Hematologist in Albany, New York. Dr. Garbo is highly rated in 86 conditions, according to our data. His top areas of expertise are Myelodysplastic Syndrome (MDS), Factor V Leiden Thrombophilia, Colorectal Cancer, and Multiple Myeloma.
New York Oncology Hematology PC
John Phelan is a Hematologist Oncology specialist and a Hematologist in Albany, New York. Dr. Phelan is highly rated in 87 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Colorectal Cancer, and Familial Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaDr. Lamparello isDistinguished. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Lamparello isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Chronic Lymphocytic Leukemia (CLL)Dr. Lamparello isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Lamparello isDistinguished. Learn about Colorectal Cancer.
- Congenital Antithrombin 3 DeficiencyDr. Lamparello isDistinguished. Learn about Congenital Antithrombin 3 Deficiency.
- Familial Colorectal CancerDr. Lamparello isDistinguished. Learn about Familial Colorectal Cancer.
- Advanced
- Acute Mountain SicknessDr. Lamparello isAdvanced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Lamparello isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Lamparello isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Lamparello isAdvanced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Lamparello isAdvanced. Learn about Aplastic Anemia.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Lamparello isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Megakaryoblastic LeukemiaDr. Lamparello isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Myeloblastic Leukemia with MaturationDr. Lamparello isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Promyelocytic LeukemiaDr. Lamparello isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Soft Tissue SarcomaDr. Lamparello isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Lamparello isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.